Modern Healthcare May 1, 2020
The Centers for Disease Control and Prevention on Thursday announced a new national genomics consortium to coordinate SARS-CoV-2 sequencing across the U.S.
The effort, called SPHERES (SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance), aims to monitor changes in the virus to support public health research and diagnostic and therapeutic development.
The consortium is led by the CDC’s Advanced Molecular Detection (AMD) program, which for the past six years has helped federal, state, and local public health labs expand the use of pathogen genomics and other technologies to strengthen infectious disease surveillance and outbreak responses.
SPHERES currently includes 37 state and local public health laboratories, as well as diagnostic and genomics companies, academic institutions, and other research laboratories....
Today's Sponsors
Today's Sponsor